IntoCell and Ab Studio to Start Research Collaboration
/PRNewswire/ -- IntoCell, a South Korean biotech developing novel antibody drug conjugate (ADC) platform technologies, today announced the signing of a...
Stay updated with breaking news from Ab Studio Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- IntoCell, a South Korean biotech developing novel antibody drug conjugate (ADC) platform technologies, today announced the signing of a...
Share this article Share this article NEW YORK, May 14, 2021 /PRNewswire/ -- Researchers have discovered new ways in which the COVID-19 virus causes human immune cells to overreact, a deadly part of the disease. Led by researchers from NYU Grossman School of Medicine and the Perlmutter Cancer Center at NYU Langone Health, the new study found that SARS-CoV-2, the pandemic virus, interacts with specific proteins on immune cells, causing these cells to release abnormally high levels of immune signaling proteins called cytokines (a "cytokine storm"). These cytokines, in turn, cause fluid buildup...